Another previous study also reported that EGFR-MT lung adenocarcinomas have relatively lower 18F-FDG uptake in comparison with EGFR-WT tumors (21), and SUVmax of patients EGFR-21-MT was higher than that of EGFR-19-MT (22). The gene discussed is EGFR; the disease is lung adenocarcinoma.